Tempus

Showing 2 posts of 2 posts found.

testalize-me-0je8ynv4mis-unsplash

Tempus receives FDA Breakthrough Device Designation for its companion diagnostic test

August 16, 2023
Research and Development Diagnostics, FDA, Tempus, breakthrough device designation, diagnostic

Tempus has announced that the US Food and Drug Administration (FDA) has granted it Breakthrough Device Designation for its HLA-LOH …

Tempus receives FDA Premarket Approval for in vitro diagnostic scan

May 3, 2023
Medical Communications Diagnostics, FDA, Oncology, Tempus, in vitro

US-based artificial intelligence (AI) and precision medicine company Tempus has announced that the US Food and Drug Administration (FDA) has …

The Gateway to Local Adoption Series

Latest content